239 related articles for article (PubMed ID: 23463207)
21. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
[TBL] [Abstract][Full Text] [Related]
22. Rapid progression of antiviral treatments of chronic hepatitis C virus infection.
Pol S; Corouge M; Mallet V; Sogni P
Minerva Gastroenterol Dietol; 2013 Jun; 59(2):161-72. PubMed ID: 23831907
[TBL] [Abstract][Full Text] [Related]
23. [Antiviral treatment of chronic hepatitis C].
Berger A
Med Monatsschr Pharm; 2012 Feb; 35(2):55-60. PubMed ID: 22400430
[TBL] [Abstract][Full Text] [Related]
24. Interferon-free antiviral combination therapies without nucleosidic polymerase inhibitors.
Welzel TM; Dultz G; Zeuzem S
J Hepatol; 2014 Nov; 61(1 Suppl):S98-S107. PubMed ID: 25443350
[TBL] [Abstract][Full Text] [Related]
25. Understanding the molecular targets for new therapeutical agents in hepatitis c infection.
Vagu C; Sultana C; Ruţă S
Roum Arch Microbiol Immunol; 2013; 72(1):5-24. PubMed ID: 23947011
[TBL] [Abstract][Full Text] [Related]
26. Future of hepatitis C therapy: development of direct-acting antivirals.
Dore GJ; Matthews GV; Rockstroh J
Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus resistance to protease inhibitors.
Halfon P; Locarnini S
J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
[TBL] [Abstract][Full Text] [Related]
28. Future perspectives: towards interferon-free regimens for HCV.
Gane E
Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654
[TBL] [Abstract][Full Text] [Related]
29. [Chronic hepatitis C infection--eradication of the virus].
Ben Ari Z
Harefuah; 2014 Jul; 153(7):392-3, 433. PubMed ID: 25189028
[TBL] [Abstract][Full Text] [Related]
30. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
Halfon P; Sarrazin C
Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
[TBL] [Abstract][Full Text] [Related]
31. Novel therapies for hepatitis C: insights from the structure of the virus.
Fusco DN; Chung RT
Annu Rev Med; 2012; 63():373-87. PubMed ID: 21942423
[TBL] [Abstract][Full Text] [Related]
32. The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir.
Marks KM; Jacobson IM
Antivir Ther; 2012; 17(6 Pt B):1119-31. PubMed ID: 23188750
[TBL] [Abstract][Full Text] [Related]
33. [Direct antiviral treatment strategies in chronic hepatitis C].
Neumann-Haefelin C; Blum HE; Thimme R
Dtsch Med Wochenschr; 2012 Jun; 137(25-26):1360-5. PubMed ID: 22653493
[TBL] [Abstract][Full Text] [Related]
34. The role of HCV proteins on treatment outcomes.
Kumthip K; Maneekarn N
Virol J; 2015 Dec; 12():217. PubMed ID: 26666318
[TBL] [Abstract][Full Text] [Related]
35. Current and future therapies for hepatitis C virus infection: from viral proteins to host targets.
Imran M; Manzoor S; Khattak NM; Khalid M; Ahmed QL; Parvaiz F; Tariq M; Ashraf J; Ashraf W; Azam S; Ashraf M
Arch Virol; 2014 May; 159(5):831-46. PubMed ID: 23979177
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C treatment: an incipient therapeutic revolution.
deLemos AS; Chung RT
Trends Mol Med; 2014 Jun; 20(6):315-21. PubMed ID: 24636306
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of hepatitis C: current status and perspectives].
Pol S; Corouge M
Rev Prat; 2014 May; 64(5):605-12. PubMed ID: 24923038
[TBL] [Abstract][Full Text] [Related]
38. New treatments for chronic hepatitis C: an overview for paediatricians.
Serranti D; Indolfi G; Resti M
World J Gastroenterol; 2014 Nov; 20(43):15965-74. PubMed ID: 25473150
[TBL] [Abstract][Full Text] [Related]
39. Treatment of hepatitis C: perspectives.
Pol S; Corouge M
Med Mal Infect; 2014 Oct; 44(10):449-54. PubMed ID: 25174659
[TBL] [Abstract][Full Text] [Related]
40. Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues.
Brown NA
Expert Opin Investig Drugs; 2009 Jun; 18(6):709-25. PubMed ID: 19426125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
